Gilead released data showing that an HIV drug, called lenacapavir, could provide virtually complete protection against ...

The analysis, based on data from sources including the USP Medicine Supply Map, found that 71% of the drugs identified as the most vulnerable are injectables, including sodium chloride injection, ...

A team of pharmaceutical researchers at biopharma company Gilead Sciences has announced that a reformulation of its HIV ...

People who inject drugs are eligible for PrEP in many countries. For example, in the United States, the Centers for Disease Control and Prevention recommends PrEP if you have an injection partner ...

Many trans people considering using the HIV prevention medication PrEP have concerns about side effects and drug interactions, and in particular whether PrEP drugs might interfere with ...

The study is the latest in a series of trials exploring lenacapavir’s role as HIV PrEP. PURPOSE 1 is comparing the drug to Truvada in approximately 5,000 cisgender women in South Africa and ...